Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open Label Study of the Efficacy and Safety of Rasburicase in the Treatment of Prophylysis for Tumor Lysis Syndrome

NCT00651911 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00651911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00651911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open Label Study of the Efficacy and Safety of Rasburicase in the Treatment of Prophylysis for Tumor Lysis Syndrome
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2003
Completion date
July 31, 2004
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tumor lysis syndrome